Healthcare ❯ Clinical Trials

Phase 3 Trials

Drug Efficacy Checkpoint Inhibitors Patient Adherence SYNCHRONY Programme Regulatory Milestones Solid Tumors Intervention Studies Treatment Efficacy

FDA Grants National Priority Voucher to J&J’s Tecvayli–Darzalex Combo in Multiple Myeloma

The voucher shortens FDA review to one to two months post‑submission.

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

Weekly Oral Risperidone Pill Maintains Steady Levels in Phase 3 Schizophrenia Trial

Inherited Mitochondrial Variant Linked to Checkpoint Inhibitor Resistance in Metastatic Melanoma